- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Estrofem
Total 2066 results
-
Semnan University of Medical SciencesTerminatedPolycystic Ovary Syndrome | Hyperandrogenism
-
Austrian Breast & Colorectal Cancer Study GroupAstraZeneca; Novartis PharmaceuticalsCompletedBreast CancerAustria, Germany
-
Shayna Showalter, MDActive, not recruitingBreast Cancer FemaleUnited States
-
Cairo UniversityUnknown
-
Gruppo Italiano Mammella (GIM)Unknown
-
Mansoura UniversityCompleted
-
Cancer Institute and Hospital, Chinese Academy...PfizerEnrolling by invitation
-
The Netherlands Cancer InstituteTerminated
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedBrain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Metastatic CancerUnited States
-
Centre Oscar LambretUnknown
-
Blokhin's Russian Cancer Research CenterRecruitingBreast Cancer Stage IVRussian Federation
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Hadassah Medical OrganizationUnknownAnemia | Chronic Kidney Disease Stage 5
-
Laval UniversityV Joseph; C Minville; C RheaumeRecruitingSleep Apnea | Oxidative Stress | Post MenopausalCanada
-
Canadian Cancer Trials GroupHoffmann-La RocheActive, not recruiting
-
University of Wisconsin, MadisonContext Therapeutics Inc.TerminatedMetastatic Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Terminated
-
Mayo ClinicCompleted
-
Bristol-Myers SquibbCompleted
-
Accelerated Community Oncology Research NetworkHoffmann-La Roche; AstraZenecaCompletedMetastatic Breast CancerUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Hoffmann-La RocheRecruitingBreast CancerCanada, Belgium, Korea, Republic of, United States, China, Taiwan, Mexico, Brazil, Argentina, Australia, Italy, Spain, Turkey, Thailand, United Kingdom, Poland, South Africa
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Recruiting
-
AstraZenecaRecruitingLocally Advanced (Inoperable) or Metastatic Breast CancerSpain, Denmark, United States, Korea, Republic of, Germany, Belgium, Vietnam, United Kingdom, France, Japan, Canada, China, India, Malaysia, Taiwan, Thailand, Australia, Turkey, Argentina, Brazil, Poland, Sweden, Italy
-
University of Kansas Medical CenterNational Cancer Institute (NCI)RecruitingBreast Cancer | Risk ReductionUnited States
-
Eisai Co., Ltd.Active, not recruiting
-
Nancy Chan, MDMerck Sharp & Dohme LLCActive, not recruiting
-
GTxCompletedPreneoplastic Conditions | Prostatic Intraepithelial NeoplasiaUnited States, Argentina, Canada
-
University of ArkansasOSI PharmaceuticalsTerminated
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Syndax PharmaceuticalsWithdrawn
-
GTxCompletedProstate Cancer | Osteoporosis | FracturesUnited States, Mexico
-
Satakunta Central HospitalTampere UniversityCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedPostmenopauseUnited States
-
National Center for Research Resources (NCRR)Unknown
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLCRecruitingMetastatic Breast CancerUnited States
-
Fudan UniversityChongqing University Cancer Hospital; Sun Yat-sen University; Peking University... and other collaboratorsRecruitingBreast Cancer MetastaticChina
-
Duke UniversityActive, not recruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | Hormone Receptor Positive TumorUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2+/HR+ Breast CancerUnited States, Spain, Canada
-
Dana-Farber Cancer InstituteNovartisCompleted
-
Fudan UniversityCompletedMetastatic Breast CancerChina
-
Instituto PalaciosPfizerCompletedOsteoporosis, PostmenopausalSpain
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Guangzhou University of Traditional Chinese MedicineUniversity of HoustonRecruitingXiao Chai Hu Tang | Irinotecan-induced DiarrheaChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingPremenopausal Breast Cancer | Hormone-receptor-positive Breast Cancer | Breast Cancer Patients at Intermediate to High Risk | Ovarian Function Suppression Combined With Aromatase Inhibitor or Tamoxifen or TorimefenChina
-
Weill Medical College of Cornell UniversityRecruitingTestosterone DeficiencyUnited States
-
NRG OncologyNational Cancer Institute (NCI)RecruitingStage I Breast CancerUnited States, Canada, Hong Kong
-
University Hospital, LilleMinistry of Health, France; Laboratoires Besins InternationalRecruitingPolycystic Ovary Syndrome | Reproductive MedicineFrance
-
European Organisation for Research and Treatment...Sanofi; Novartis; Roche Pharma AG; Breast International Group; AgendiaCompleted